Pharmacy Podcast Network

Pharmacy Tech Giants Working Together to help Pharmacies Succeed |Pharmacy CrossRoads

In December of 2020 PioneerRx was acquired by RedSail Technologies.  RedSail is a new company that has emerged as an industry powerhouse via its acquisition n in 2019 of QS1, one of the industries oldest and most well know pharmacy technology companies and now, PioneerRx.    
In this podcast Jeff Key, President of PioneerRx chats with Kraig McEwen, CEO of RedSail.  During the interview together they outline the reasons the two companies have joined together and provide some insight into how they plan to work together to provide pharmacy owners with the tools, resources and information they need to succeed. 
One key thing they discuss is that they do not plan to merge QS1 and PioneerRx but allow them both to operate separately. 
McEwen outlines his professional background and assures current and potential PioneerRx users that Jeff Key and the PioneerRx management team, and philosophy, will remain unchanged.
Jeff Key explains that PioneerRx hasd known for a year or more that in order to grow and improve that more resources would be needed and so PioneerRx and their parent company, Morris and Dickson Wholesale Drug, agreed to look for a business partner that could provide those resources. 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

That Really Ticks Me Off | GameChangers

Lyme disease is a complex infection and post infection syndrome can lead to serious outcomes, including death. A new guideline was developed for the diagnosis and treatment of this infection. Spoon!
This episode is accredited for CPE. Subscribe at CEimpact
( https://www.ceimpact.com/pharmacist ) and claim your CE today!
Reference: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. Clinical Infectious Diseases, November 30, 2020. https://doi.org/10.1093/cid/ciaa1215. Accessed at
https://www.idsociety.org/practice-guideline/lyme-disease/ 
CPE details for GameChangers Podcast February 2021
Learning Objective: Discuss treatment for different forms of lyme disease infections depending on the severity of symptoms
0107-0000-21-XXX-H01-P
0.2 CEU/2.0 Hrs (Knowledge)
Initial Release Date: 02/23/21
Expiration Date: 02/23/24
Additional CPE information is located at https://www.ceimpact.com/podcast 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharmacy CrossRoads | Pharmacy Owner Richard Ost RPh

Today's special guest is Pharmacy owner & Community Champion Mr. Rich Ost, R.Ph., owner of Philadelphia Pharmacy located in Philadelphia, PA. 
Philadelphia Pharmacy is a well-known and respected establishment in downtown Philadelphia.  It has been located on the corner of N. Front St. and E. Leigh for nearly 40 years and is owned by Richard Ost, RPh.  In a city famous for buildings painted with colorful mural, the pharmacy boasts one of the city’s most notable.  The corner locations is wrapped in a 3 story tall mural, on both the store front and side of the building that colorfully represents the evolution of medicine from botanicals to modern day prescriptions.    
In this episode of Pharmacy CrossRoads Ost tells Bruce Kneeland how, on Oct. 27, 2020, social unrest and rioting resulted in the looting of his pharmacy and several others in the City.  Ost tells how, with the help of his staff, the community and suppliers the pharmacy was completely put back together and in a matter of days was once again serving the community.  Ost also provides some words of advice for pharmacy owners on how they can prepare for this type of thing. 
Ost also share some tips on how he and his team, over the past years have worked to earn the trust, support and patronage of the community.  He says it takes time, creativity and building relationships of trust best earned by treating people with respect, adjusting to ethnic needs and simply providing people with top notch care.   
Thank you to CPA the Compliant Pharmacy Alliance Cooperative for sponsoring the Pharmacy CrossRoads Podcast.  
CPA is proud to serve independent pharmacy owners. For over 25 years, we have made your business, our business. With over 2,000+ member pharmacies, CPA leverages an exceptional membership and our expertise to obtain market leading economics, services, and support. Being a 100% member-owned cooperative, there are no conflicts of interest.
Learn more:
https://members.compliantrx.com/
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Data Science & A.I. | FutureDose Tech

In the future data science and artificial intelligence will be routinely used to give clinicians diagnostic recommendations; give scientists testable hypotheses they can confirm experimentally and offer them insights into safe and precise treatments; and give patients guidance on self-care, e.g., how to lead a healthy lifestyle and recognize disease early.
Marinka Zitnik, PhD is an Assistant Professor of Biomedical Informatics, Harvard Medical School. Before joining Harvard, Dr. Zitnik was a postdoctoral fellow in Computer Science at Stanford University and was involved in projects at Chan Zuckerberg Biohub. Listen in as David and Marinka explain some AI concepts such as encoding, decoding, and embedding as well as discuss algorithms that can predict drug-drug interactions and identify medications that may be good candidates to treat COVID-19. 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Mark Cuban’s Cost Plus Drugs w/ CEO Dr. Alex Oshmyansky, MD, PhD

The new podcast called “Decoder with Nilay Patel” episode 1 @reckless released on Nov 10, 2020 with special guest MARK CUBAN ON AMERICA’S FUTURE & a short clip about Cost Plus Drugs.
Alex Oshmyansky, MD, PhD is the CEO & Founder at Mark Cuban Cost Plus Drug Company.
Dr. Alex along with strategic investor & business mogul Mark Cuban has launched Mark Cuban Cost Plus Drug Company, a pharmaceutical company that plans to make less expensive versions of selected generic drugs.  The company's first drug is a generic version of albendazole, an antiparasitic drug used to treat hookworm. Treated early, two tablets will treat the infection; left untreated, cognitive defects and neurological problems can result.
Cost Plus Drug Company is dedicated to producing low-cost versions of high-cost generic drugs.
In this interview, Dr. Alex pledges to provide radical transparency in how they price their drugs.  Dr. Alex has committed letting everyone know what it costs to manufacture, distribute, and market drugs to pharmacies. They will add a flat 15% margin to get wholesale prices. This will help to ensure they remain viable and profitable. There are no hidden costs, no middlemen, no rebates only available to insurance companies. Everybody gets the same low price for every drug they make.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

A Mother’s Strength & Resilience of a Daughter w/ Brain Cancer | Team Livi

Special Episode:
A Mother's Strength & Resilience of a Daughter w/ Brain Cancer | Team Livi 
Todd Eury here, founder of the Pharmacy Podcast Network, with a first for our listeners since launching in 2009, I interview the most important person in healthcare, our patient. The mother of a little 10 year old girl, Livi, who has brain cancer. 
Livi's mother is Shannon Sealy, from my home town, Brownsville Pennsylvania. 
Help Livi Beat Brain Cancer
CLICK HERE TO DONATE: 
https://www.gofundme.com/f/help-livi-beat-brain-cancer?rcid=bae1ad4959be44a795bf8566e381dc7a&utm_campaign=p_na+share-sheet&utm_medium=copy_link&utm_source=customer 
Data from this episode: 
Corticosteroids in brain cancer patients: benefits and pitfalls 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109638/ 
Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood: 
https://pubmed.ncbi.nlm.nih.gov/8487049/ 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Closer to the Heart | GameChangers

In December 2020, the American College of Cardiology published an Expert Consensus Decision Pathway for Antithrombotic Therapy in Patients undergoing Percutaneous Coronary Intervention. This guideline addresses a timely problem of patients on anticoagulation and antiplatelet therapy.
This episode is accredited for CPE. Subscribe at CEimpact ( https://www.ceimpact.com/pharmacist ) and claim your CE today!
Reference: 2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. Dec 18, 2020. Epublished DOI: 10.1016/j.jacc.2020.09.011. Accessed at https://www.jacc.org/doi/10.1016/j.jacc.2020.09.011
CPE details for GameChangers Podcast January 2021
Learning Objective: Recommend an appropriate antithrombotic/anticoagulant regimen in a patient who has received percutaneous coronary intervention with stenting
0107-0000-21-079-H01-P
0.2 CEU/2.0 Hrs (Knowledge)
Initial Release Date: 01/25/21
Expiration Date: 01/26/24
Additional CPE information is located at https://www.ceimpact.com/podcast
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharmacist’s Guide to COVID-19 Testing | Beyond the Sig

On this episode of Beyond the Sig, third-year student pharmacist Brooke Kulusich chats with Garrett Sipes, PharmD of Chambers’ Apothecary in Chambersburg, Pennsylvania. Recently, this pharmacy has successfully implemented COVID-19 testing. Garrett walks us through this process step-by-step and shares valuable lessons learned for pharmacists looking to get involved. 
All the PPA Podcasts: https://www.papharmacists.com/page/podcast 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

The Pharmacist’s Impact: Reimagined the Life Sciences Beyond COVID-19

Today's special guest is Susan Garfield, DrPH, Principal | Commercial Lead | Health Sciences and Wellness Sector with Ernst & Young LLP. Susan is an author on the study titled: Reimagined the Life Sciences Beyond COVID-19
Summary: 
From payer-mix changes, to pricing and profitability concerns, COVID-19 has made the biopharma industry fraught with market and other pressures. However, these circumstances have also presented new opportunities, including accelerated adoption of digital tools and approaches. This was all made clear when we, in association with EY, surveyed 550+ biopharma executives - from R&D to commercial – to gain practical insights on the current state and long-term outlook for the industry.
This new free report ‘Beyond COVID-19: Life sciences reimagined’ highlights key findings from our analysis and is intended to help establish a framework for more patient-focused, sustainable care delivery post-crisis. Download this 30+ page report and:
See the impact of COVID-19 across the product lifecycle, highlighting commercial, HCP needs and relationships, marketing and the sales model, patient engagement, medical affairs and R&D – with one of the largest surveys of senior-pharma professionals during the pandemic
Hear from pharma leaders who are plotting the industry’s re-mergence strategies into the “new normal”
Benchmark your own response and experience to COVID-19 against hundreds of industry peers
Download this 30+ page report for free here.
Insights from industry leaders, include:
Karan Arora, Chief Commercial Digital Officer, AstraZeneca
Chetak Buaria, Global Head of Customer Engagement & Channel Evolution, Biopharma Global, Merck
Kabir Nath, President, Otsuka North America Pharmaceutical Business
Harmony Garges, CMO, ViiV Healthcare 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

My Shot! | GameChangers

The unbelievable happened in 2020 - a vaccine was developed with high efficacy within 12 months for a novel virus! In December two vaccines for the prevention of the SARS-CoV-2 virus were approved through Emergency Use Authorization in the US. Is it time to get a shot?
This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!
Reference: Polack F, Thomas S, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine. NEJM. Dec 10, 2020. DOI: 10.1056/NEJM2034577
Baden L, El Sahly H, Essink B, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. NEJM. Dec 30, 2020. DOI: 10.1056/NEHMoa2035389
ACIP Recommendations: https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/covid-19.html 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Medical Information Leader Ina Shah, PharmD, BCMAS | Occupation Station

Ina Shah entered Albany College of Pharmacy and Health Sciences through the non-traditional Doctor of Pharmacy degree program.  After successfully balancing the demands of work and school, she graduated in 2001 ready for a career in the industry.  Now she’s the executive director medical information for Abbvie. 
Ina credits the ACPHS Pharm D program with preparing her for this essential work by giving her a clinical background, exposing her to a wide variety of therapeutics, and helping her hone her expertise in medical writing. 
In this edition of Occupation Station, Ina talks about the challenges in the field, communicating essential information to both consumers and members of the medical community through multiple communications channels.   She also talks about the excitement of being an essential part of Phase 3 and Phase 4 drug trials, where her critical thinking and communication skills are called upon during the regulatory process of applying for an NDA or SNDAs for new products.
This episode of the Pharmacy Podcast Network was sponsored by AudioRx.study 
AudioRx is the first Uber-Podcasting platform for the Pharmacy Industry. 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Top 5 Professionals to Have Available When Starting Your Compounding Pharmacy

Quick podcast from Darshan Kulkarni, PharmD, Esq., about hiring the right 5 people to help you build a successful compounding business. 
This episode is sponsored by AudioRx.study. 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharma Strikes Back | PUTTcast

Join hosts Monique Whitney and Scott Newman, with this month's special guests Medicure President, Neil Owens, and Marley Drug founder, Dave Marley. They'll discuss the problems of PBM involvement in the prescription drug supply chain from a drug manufacturer's perspective, and how, by joining forces, PBMs can be removed from the equation. 
Learn more at TruthRx.org
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Perspectives On The APhA Practice Guidance For Pharmacy-Based Medication Administration Services | PsychU Podcast

In this interview, Dr. Leland shares his perspectives on the APhA practice guidance requirements for pharmacy-based MAS from the context of his experience as a Pharmacy Manager. The Practice Guidance For Pharmacy-Based MAS was developed in 2017 by the APhA, and can be accessed on PsychU here.
Rob Leland, PharmD, is the Pharmacy Manager & Owner of First Avenue Pharmacy in Spokane, Washington; the first pharmacist-run long-acting injectable clinic in the State of Washington. He recently served on the advisory board for the American Pharmacists Association (APhA) Pharmacy-Based Medication Administration Services (MAS) Guide.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Package Performance Qualification – What it Is, Why it’s Important and How it Works | NASP Podcast

Topic: Package Performance Qualification (PPQ) Testing for URAC 4.0 Compliance & PBM Contracting
Participants and Roles:          
Sheila Arquette, President & CEO, NASP, Host/Interviewer
Katie Kraverath, Sr. Business Development Manager, Temptime Corporation
Bill Barrows, Program Director, Partner’s Healthcare Specialty Pharmacy
What you’ll learn:
Why it’s important to perform seasonal package performance qualification (PPQ) testing.
URAC and PBM requirements for PPQ Testing.
Processes and methods of testing, including third-party testing vs in-house testing.
An overview of changes to PPQ testing requirements per URAC’s new 4.0 version.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

A Story about a Patient | Beyond the Sig

If you didn’t document it, it didn’t happen.  In this episode of Beyond the Sig, Stephanie McGrath, PharmD, Executive Director of the Pennsylvania Pharmacists Care Network sits down with Josh Howland of PioneerRx and Kristen Hartzell of Hartzell’s Pharmacy to discuss how technology is supporting pharmacists in documenting their impact on patient care in an unprecedented way. 
Documentation through the Pharmacist’s eCare Plan is a key component of the Flip the Pharmacy initiative, and a driver in community pharmacy practice innovation.  But at the end of the day, it’s just a story about a patient.  
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Hearts Don’t Break Around Here | GameChangers

Every December, the American Diabetes Association updates the Standards of Medical Care in Diabetes. The guidelines cover sixteen sections from diabetes advocacy to technology updates. Start 2021 off right - learn what changed and what matters most for individuals with diabetes.
This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!
Reference: American Diabetes Association. Standards of Medical Care in Diabetes - 2021. Diabetes Cares. January 01, 2021; volume 44, issue supplement 1. https://care.diabetesjournals.org/content/44/Supplement_1 
Disclosure: Dr. Jake Galdo is a speaker for Novo Nordisk in 2021.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

The Next Phase of Pharmacogenomics & the Pharmacist | PGX for Pharmacists

Becky Winslow, PharmD & Pharmacy Student Kaitlyn Marshall re-launch the PGX for Pharmacists. 
23andMe announced in August of 2020 that it has received a 510(k) clearance from the FDA that allows its direct-to-consumer personal pharmacogenetics report to guide use of two treatments without the need for confirmatory testing.
This action updates a De Novo approval granted to the consumer genomics company in late 2018. That decision allowed 23andMe to market a test for one of 33 variants across multiple genes that could impact metabolization of certain medication, but came with a handful of "special controls." Among these were labeling requirements that warned consumers not to use the product for any medication decisions without additional independent testing.
Guests: 
Becky Winslow, BS, PharmD - Medical Affairs 
Dr. Becky Winslow, earned both her Bachelors of Science in Biology and her doctorate in clinical pharmacy from Campbell University. She earned her Test2Learn(TM) Community-Based Pharmacogenomics Certificate, as well as, her  "Train the Trainer"  certification through NACDS and The University of Pittsburgh School of Pharmacy. 
Dr. Winslow brings over 20 years experience building clinical pharmacy programs, as well as, directing pharmacy business operations in the community setting to inGENEiosu RX. She has patient facing clinical experience as a pharmacist in retail, hospital, public health, and long term care pharmacies. Dr. Winslow founded and has owned her general pharmacy consulting business for over 20 years. In the last 6 years, she has specialized in pharmacogenomics consulting. 
Dr. Winslow's professional associations include being a member of the Clinical Pharmacogenetics Implementation Consortium and The Get the Medications Right Institute.
Now recognized as a community pharmacogenomics subject matter expert, Dr. Winslow is sought after to create and present original pharmacogenomics content and to consult for pharmacogenomics industry vendors and the clients they serve.
Kaitlyn Marshall - PharmD Candidate 2021
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Student Perspective: Engaging Students in Community Pharmacy Practice Transformation | Beyond the Sig

On this episode of Beyond the Sig, Brooke Kulusich, third-year student pharmacist at the University of Pittsburgh School of Pharmacy, talks with Cameron Carpenter, fourth-year student pharmacist at Wilkes Nesbitt School of Pharmacy. In this student-to-student conversation, they discuss ways to engage student pharmacists in practice transformation efforts and Cameron shares his experience from completing an elective community APPE rotation at leading PPCN pharmacies across the state.
Beyond the Sig
https://www.papharmacists.com/page/podcast 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Connecting the dots for better Health & the MOBE Pharmacist

Look at the big picture with a MOBE Pharmacist.
From your past health history to any new or recent treatments, a MOBE Pharmacist is here to help you put it all together.
They help you build the best medication plan for your health goals by looking at all your prescriptions—across providers, pharmacies, and clinics—and listening to your concerns, as well as what has or hasn’t worked in the past.
You’ll also learn more about how any over-the-counter drugs, dietary supplements, and/or herbal remedies fit into your treatment plan. Your pharmacist will partner with your MOBE Guide to optimize any lifestyle changes you might make to best support your medication situation.
When access isn’t enough: Solving a paradox to serve healthcare’s hidden population. By: Chris Cronin, Chief Executive Officer
https://www.mobeforlife.com/resources/when-access-isnt-enough-solving-a-paradox-to-serve-healthcares-hidden-population
Promoting patient engagement to prevent readmissions By: Leslie Helou, Vice President of Guided Medication Programming
https://www.mobeforlife.com/resources/promoting-patient-engagement-to-prevent-readmissions
Our guests:
Leslie Helou, PharmD, BCPS
Vice President of Medication Strategies
Leslie designs medication initiatives for MOBE participants that are hyper-personalized. These action plans address the complexity of each medication while highlighting the important role they can play when achieving health goals. She inspires her team to help others think critically about, understand, and get the best results possible from their medications while also making other healthy choices. Prior to joining MOBE, Leslie built a career at Upsher-Smith Laboratories, leading efforts to incorporate patient, provider, researcher, and advocacy group insights early in the pharmaceutical research and development process.
Leslie received a doctorate in pharmacy from the University of Minnesota College of Pharmacy before completing a multi-year post-graduate residency in pharmaceutical care and leadership and becoming board certified in pharmacotherapy. She is passionate about mentoring and keeps a relationship with the University to provide unique, business-focused experiences to pharmacy students and graduates.
 Chris Cronin
Chief Executive Officer
Chris leads corporate direction and strategy at MOBE and is motivated daily by guiding the team to do good together. He previously served as the company’s Chief Operating Officer.
Prior to joining MOBE, Chris held various leadership positions at Medtronic in the Cardiac and Restorative Therapies Group, including European Business Director and leading the commercialization of the world’s first MR-Conditional Pacemaker.
Chris has a BS in Accounting from St. John’s University and an MBA from The University of Notre Dame. He lives an active, healthy lifestyle and has completed 15 marathons and three Ironman triathlons, but still loves a big bowl of ice cream.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices